“Impact Of Personal Protective Equipment On Pediatric Cardiopulmonary Resuscitation Performance: A Controlled Trial.”. Pediatr Emerg Care 36 (6). Pediatr Emerg Care: 267-273. doi:10.1097/PEC.0000000000002109.
. 2020. “Impact Of Personal Protective Equipment On The Performance Of Emergency Pediatric Tasks.”. Pediatr Emerg Care. Pediatr Emerg Care. doi:10.1097/PEC.0000000000002028.
. 2020. “Impact Of Personal Protective Equipment On The Performance Of Emergency Pediatric Procedures By Prehospital Providers.”. Disaster Med Public Health Prep. Disaster Med Public Health Prep: 1-8. doi:10.1017/dmp.2020.128.
. 2020. “Electronic Self-Administered Screening For Substance Use In Adult Primary Care Patients: Feasibility And Acceptability Of The Tobacco, Alcohol, Prescription Medication, And Other Substance Use (Mytaps) Screening Tool.”. Addict Sci Clin Pract 14 (1). Addict Sci Clin Pract: 39. doi:10.1186/s13722-019-0167-z.
. 2019. “Dsm-5 Substance Use Disorders Among Adult Primary Care Patients: Results From A Multisite Study.”. Drug Alcohol Depend 179. Drug Alcohol Depend: 42-46. doi:10.1016/j.drugalcdep.2017.05.048.
. 2017. “Validation Of The Taps-1: A Four-Item Screening Tool To Identify Unhealthy Substance Use In Primary Care.”. J Gen Intern Med 32 (9). J Gen Intern Med: 990-996. doi:10.1007/s11606-017-4079-x.
. 2017. “Design Of The Nida Clinical Trials Network Validation Study Of Tobacco, Alcohol, Prescription Medications, And Substance Use/misuse (Taps) Tool.”. Contemp Clin Trials 50. Contemp Clin Trials: 90-7. doi:10.1016/j.cct.2016.07.013.
. 2016. “Hair Analysis And Its Concordance With Self-Report For Drug Users Presenting In Emergency Department.”. Drug Alcohol Depend 167. Drug Alcohol Depend: 149-55. doi:10.1016/j.drugalcdep.2016.08.007.
. 2016. “Performance Of The Tobacco, Alcohol, Prescription Medication, And Other Substance Use (Taps) Tool For Substance Use Screening In Primary Care Patients.”. Ann Intern Med 165 (10). Ann Intern Med: 690-699. doi:10.7326/M16-0317.
. 2016. “Utilizing A Two-Stage Design To Investigate The Safety And Potential Efficacy Of Monthly Naltrexone Plus Once-Daily Bupropion As A Treatment For Methamphetamine Use Disorder.”. J Addict Med 10 (4). J Addict Med: 236-43. doi:10.1097/ADM.0000000000000218.
. 2016. “Achieving Cannabis Cessation -- Evaluating N-Acetylcysteine Treatment (Accent): Design And Implementation Of A Multi-Site, Randomized Controlled Study In The National Institute On Drug Abuse Clinical Trials Network.”. Contemp Clin Trials 39 (2). Contemp Clin Trials: 211-23. doi:10.1016/j.cct.2014.08.011.
. 2014. “Brief Intervention For Patients With Problematic Drug Use Presenting In Emergency Departments: A Randomized Clinical Trial.”. Jama Intern Med 174 (11). Jama Intern Med: 1736-45. doi:10.1001/jamainternmed.2014.4052.
. 2014. “Multisite, Randomized, Double-Blind, Placebo-Controlled Pilot Clinical Trial To Evaluate The Efficacy Of Buspirone As A Relapse-Prevention Treatment For Cocaine Dependence.”. J Clin Psychiatry 75 (7). J Clin Psychiatry: 757-64. doi:10.4088/JCP.13m08862.
. 2014. “Design Considerations For A Study To Evaluate The Impact Of Smoking Cessation Treatment On Stimulant Use Outcomes In Stimulant-Dependent Individuals.”. Contemp Clin Trials 33 (1). Contemp Clin Trials: 197-205. doi:10.1016/j.cct.2011.09.018.
. 2012. “Evaluation Of Buspirone For Relapse-Prevention In Adults With Cocaine Dependence: An Efficacy Trial Conducted In The Real World.”. Contemp Clin Trials 33 (5). Contemp Clin Trials: 993-1002. doi:10.1016/j.cct.2012.05.003.
. 2012.